Get the Weekly Intelligence Brief — top committee picks every Sunday.

ALC vs IONS

Alcon Inc vs Ionis Pharmaceuticals, Inc. — AI-powered side-by-side comparison
ALC
Alcon Inc
68
Buy
VS
IONS
Ionis Pharmaceuticals, Inc.
43
Reduce
MetricALCIONS
AI Score 68 43
Price $75.39 $55.38
P/E Ratio 45.39× -16.02×
ROE 4.4% -77.9%
Revenue Growth YoY
Gross Margin 54.9% 98.2%
Debt / Equity 0.24× 5.50×
Dividend Yield 0.5% 0.0%
RSI (14) 73.4 46.6
Beta 0.703 0.4
Expected Upside +11.3%

AI Committee View

Current Innellis committee reasoning for ALC versus IONS.
ALC leads by 25 points.

ALC scores 68/100 (Buy) versus IONS at 43/100 (Reduce).

ALC Committee View
75% agreement
4 analysts

The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is rsi at 73 is in overbought territory. The committee is constructive but not yet at full conviction.

Bull Case
  • Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
  • RSI at 73 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
IONS Committee View
50% agreement
6 analysts

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -7.5% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull Case
  • MACD histogram positive -- bullish momentum — Technical
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
  • Price-to-book of 26.2x prices in significant intangible value — Value
  • ROE of only -110.9% -- cheap may mean cheap for a reason — Value
  • Debt-to-equity of 4.77 adds balance-sheet risk to the value case — Value
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
ALC Full Analysis IONS Full Analysis